Invenra is a company focused on developing biologics with an emphasis on multispecific antibodies and their derivatives. Its B-Body and SNIPER technologies are used to develop antibodies that can bind to two or more specific therapeutic targets and mimic the natural IgG antibodies made by the human body. The company has a pipeline of immuno-oncology bispecific antibodies.